Home > Healthcare > Medical Devices > Vitrification Market
Vitrification Market size was valued at USD 7.9 billion in 2023, growing at a CAGR of 10.1% between 2024 and 2032. Vitrification is a rapid freezing technique used in cryopreservation to convert a liquid into a glass-like solid without the formation of ice crystals. This method is particularly valuable in preserving biological specimens such as embryos, oocytes, and stem cells, as it minimizes cellular damage during the freezing and thawing processes.
Further, vitrification maintains the integrity and viability of the preserved materials, making it a preferred technique in fields such as reproductive medicine and biotechnology. The market is experiencing dynamic growth driven by increasing demand for advanced cryopreservation techniques in fertility treatments. The WHO estimates that 60 to 80 million couples globally experience infertility. Southern and Eastern Europe, along with East Asia, have some of the lowest fertility rates, averaging 1.5 children per woman. Similarly, it is observed that the use of assisted reproductive technology (ART) has grown by 5% to 10% annually.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Vitrification Market Size in 2023: | USD 7.9 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 10.1% |
2032 Value Projection: | USD 18.7 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 120 |
Tables, Charts & Figures: | 242 |
Segments covered: | Product Type, Specimen, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
This rise in ART has led to increased demand for fertility treatments, thereby boosting the need for in vitro fertilization (IVF) services. Thus, the rising demand for infertility treatments strengthens the need for the vitrification method, thereby driving market growth. Additionally, the growing focus on biobanking and regenerative medicine further fuels market expansion, as vitrification is crucial for the long-term storage of biological specimens.